Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
China Auto Logistics Inc. (NASDAQ: CALI) shares soared 46.26 percent to close at $4.30 a share Thursday. The stock traded between $4.26 and $6.89 on volume of 4.31 million shares traded. The company announced that its subsidiary has signed a definitive agreement to acquire Tianjin Zhonghe Auto Sales Service Co. for $91.4 million. Shares of China Auto Logistics have gained approximately 43.0 percent year-to-date.
Get more information on China Auto Logistics and free access to the in-depth equity report at:
www.FiveStarEquities.com/CALI
CombiMatrix Corporation (NASDAQ: CBMX) shares spiked 18.00 percent to close at $2.95 a share Thursday. The stock traded between $2.95 and $3.70 on volume 5.86 million shares traded. The company announced that the American College of Obstetricians and Gynecologists has recommended its chromosomal microarray analysis in first-line genetic testing. Shares of CombiMatrix have fallen approximately 44.0 percent year-to-date.
Get more information on CombiMatrix and free access to the in-depth equity report at:
www.FiveStarEquities.com/CBMX
Plug Power Inc. (NASDAQ: PLUG) shares surged 42.52 percent to close at $1.81 a share Thursday. The stock traded between $1.43 and $1.96 on volume 69.50 million shares traded. The company in a recent news releases stated that they expect to be profitable in 2014. Shares of Plug Power have gained approximately 260.0 percent year-to-date.
Get more information on Plug Power and free access to the in-depth equity report at:
www.FiveStarEquities.com/PLUG
Receptos Inc. (NASDAQ: RCPT) shares jumped 21.76 percent to close at $27.64 a share Thursday. The stock traded between $25.04 and $28.95 on volume 1.45 million shares traded. The company announced that it has initiated a Phase 3 trial of RPC1063 in relapsing multiple sclerosis. Shares of Receptos have gained approximately 95.0 percent year-to-date.
Get more information on Receptos free access to the in-depth equity report at:
www.FiveStarEquities.com/RCPT
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Five Star Equities
[email protected]